Related Experiment Videos
Dopamine and depression
Journal of Neural Transmission. General Section
|January 1, 1993
Summary
Dopamine plays a significant role in depression, contrary to the focus on other neurotransmitters. Evidence suggests dopamine dysfunction contributes to depressive symptoms and may be targeted by effective antidepressants.
Area of Science:
- Neuroscience
- Psychiatry
- Biochemistry
Background:
- Schizophrenia research has focused on dopamine, while depression research has emphasized norepinephrine, serotonin, and acetylcholine.
- Substantial evidence suggests dopamine's involvement in affective disorders has been overlooked.
Purpose of the Study:
- To review the clinical, biochemical, and pharmacological evidence implicating dopamine in the pathophysiology of depression.
- To highlight the underappreciated role of dopamine in mood disorders.
Main Methods:
- Review of clinical observations linking aging, Parkinson's disease symptoms, and seasonal mood disorder to dopamine.
- Analysis of biochemical studies measuring homovanillic acid (a dopamine metabolite) in depressed patients.
- Examination of pharmacological data on antidepressants with dopaminergic effects.
Main Results:
- Clinical evidence includes age-related changes in depressive symptoms, dopaminergic links in depression subtypes, Parkinson's symptom overlap, and seasonal mood disorder abnormalities.
- Biochemical studies show diminished dopamine turnover in depressed individuals, indicated by reduced homovanillic acid levels.
- Pharmacological evidence supports the efficacy of dopaminergic antidepressants in treating depression.
Conclusions:
- Dopamine significantly contributes to the pathophysiology of depression.
- The role of dopamine in depression should be considered alongside other neurotransmitter systems, acknowledging potential interactions.